Back

Is weight loss the main reason incretins reduce cardiovascular risk? - discussion

28 August 2026 (14:25 - 15:00)
Organised by: Logo
Congress Presentation Part of: Great Debate: is weight loss the main reason incretins reduce cardiovascular risk? Antidiabetic Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

2 More presentations in this session

Presentation thumbnail
Is weight loss the main reason incretins reduce cardiovascular risk?: pro
Professor A. Rosengren (Gothenburg, SE)
Video
Presentation thumbnail
Is weight loss the main reason incretins reduce cardiovascular risk?: con
Professor N. Marx (Aachen, DE)
Video

Access the full session

Session thumbnail
Great Debate: is weight loss the main reason incretins reduce cardiovascular risk?
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 14:25 CET
You may be interested in
thumbnail
Congress Presentation
Tackling the obesity tsunami: pharmacotherapy is the solution - discussion
30 August 2025
thumbnail
Congress Presentation
Diabetes, obesity, and heart failure - discussion
19 May 2025
thumbnail
Congress Presentation
How has the concept of incretin mimetics evolved since SELECT?
31 August 2025
thumbnail
Congress Presentation
GLP-1 receptor agonists therapy induces muscle loss in cardiometabolic disease: con
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources